title: Primary and revision total hip replacement in patients who are Jehovah's Witnesses.
abstract: The Jehovah's Witnesses do not accept allogeneic blood transfusion or certain types of autologous blood transfusion and, therefore, present the orthopaedic surgeon with a challenge in the management of perioperative blood loss. Accepting a patient who is a Jehovah's Witness as a surgical candidate requires the surgeon to be prepared medically to use known techniques to limit red blood cell loss or increase red blood cell mass, to resort to extraordinary means when necessary, and to be prepared philosophically to deal with catastrophic blood loss in a patient who may refuse even potentially life-saving transfusion. Issues pertinent to the management of intraoperative blood loss in the patient who is a Jehovah's Witness require careful delineation and specific treatment guidelines. The authors herein review their past and current experiences in the perioperative blood management of this patient population in an attempt to address this need.
authors.affiliation: University of Arkansas for Medical Sciences, Little Rock 72205, USA.
authors.forename: C L
authors.initials: CL
authors.lastname: Nelson
authors.forename: J G
authors.initials: JG
authors.lastname: Stewart
mesh_terms: D019644:Arthroplasty, Replacement, Hip / Q000379:methods*; D016063:Blood Loss, Surgical / Q000517:prevention & control; D001803:Blood Transfusion; D002835:Christianity; D000075202:Contraindications; D017558:Elective Surgical Procedures / Q000379:methods; D004921:Erythropoietin / Q000008:administration & dosage; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D010347:Patient Care Planning; D011300:Preoperative Care / Q000379:methods; D011994:Recombinant Proteins; D012086:Reoperation / Q000379:methods; D012449:Safety
chemical_list: D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin